220 related articles for article (PubMed ID: 25524049)
1. Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes.
Marquer C; Laine J; Dauphinot L; Hanbouch L; Lemercier-Neuillet C; Pierrot N; Bossers K; Le M; Corlier F; Benstaali C; Saudou F; Thinakaran G; Cartier N; Octave JN; Duyckaerts C; Potier MC
Mol Neurodegener; 2014 Dec; 9():60. PubMed ID: 25524049
[TBL] [Abstract][Full Text] [Related]
2. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol, lipids, amyloid Beta, and Alzheimer's.
Vestergaard M; Hamada T; Morita M; Takagi M
Curr Alzheimer Res; 2010 May; 7(3):262-70. PubMed ID: 19715550
[TBL] [Abstract][Full Text] [Related]
4. Neuronal membrane cholesterol loss enhances amyloid peptide generation.
Abad-Rodriguez J; Ledesma MD; Craessaerts K; Perga S; Medina M; Delacourte A; Dingwall C; De Strooper B; Dotti CG
J Cell Biol; 2004 Dec; 167(5):953-60. PubMed ID: 15583033
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes.
Cossec JC; Marquer C; Panchal M; Lazar AN; Duyckaerts C; Potier MC
Biochim Biophys Acta; 2010 Aug; 1801(8):839-45. PubMed ID: 20348021
[TBL] [Abstract][Full Text] [Related]
6. APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.
Maulik M; Peake K; Chung J; Wang Y; Vance JE; Kar S
Hum Mol Genet; 2015 Dec; 24(24):7132-50. PubMed ID: 26433932
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal modulation between amyloid precursor protein and synaptic membrane cholesterol revealed by live cell imaging.
DelBove CE; Strothman CE; Lazarenko RM; Huang H; Sanders CR; Zhang Q
Neurobiol Dis; 2019 Jul; 127():449-461. PubMed ID: 30885793
[TBL] [Abstract][Full Text] [Related]
8. Membrane cholesterol content plays a key role in the neurotoxicity of β-amyloid: implications for Alzheimer's disease.
Abramov AY; Ionov M; Pavlov E; Duchen MR
Aging Cell; 2011 Aug; 10(4):595-603. PubMed ID: 21332922
[TBL] [Abstract][Full Text] [Related]
9. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol modulates amyloid beta-peptide's membrane interactions.
Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: the cholesterol connection.
Puglielli L; Tanzi RE; Kovacs DM
Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-depletion corrects APP and BACE1 misstrafficking in NPC1-deficient cells.
Malnar M; Kosicek M; Lisica A; Posavec M; Krolo A; Njavro J; Omerbasic D; Tahirovic S; Hecimovic S
Biochim Biophys Acta; 2012 Aug; 1822(8):1270-83. PubMed ID: 22551668
[TBL] [Abstract][Full Text] [Related]
15. Brain-membrane cholesterol in Alzheimer's disease.
Eckert GP; Kirsch C; Müller WE
J Nutr Health Aging; 2003; 7(1):18-23. PubMed ID: 12679836
[TBL] [Abstract][Full Text] [Related]
16. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
[TBL] [Abstract][Full Text] [Related]
17. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
[TBL] [Abstract][Full Text] [Related]
18. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.
Cutler RG; Kelly J; Storie K; Pedersen WA; Tammara A; Hatanpaa K; Troncoso JC; Mattson MP
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2070-5. PubMed ID: 14970312
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.
Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA
Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385
[TBL] [Abstract][Full Text] [Related]
20. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
